News-Medical.Net on MSN
Study tests combined targeted radiopharmaceuticals and precision radiation for recurrent prostate cancer
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...
COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Lahjavida Bio, a biotechnology company ...
11don MSN
Pancreatic cancer is among the deadliest cancers: New drug is giving patients and doctors hope
Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...
MedPage Today on MSN
Targeted Drug for Advanced Pancreatic Cancer Sparks Early Enthusiasm
SAN FRANCISCO -- Almost 80% of patients with heavily pretreated advanced/metastatic pancreatic cancer achieved disease ...
Explore the potential of polysaccharide microneedles in cancer immunotherapy for effective drug delivery and immune ...
The startup is developing a medicine that can very specifically degrade cancerous forms of EGFR, the target of an array of ...
A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...
The FDA and European Medicines Agency (EMA) have awarded orphan drug designation to CPI-008 (cRGD-ZW800-1), a novel ...
The financing, which will back a novel type of cancer drug, is the largest of a series of startup fundings announced at the ...
Cancer diagnoses are both more common and more survivable than ever. The question is whether you can afford life-saving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results